Back to search

Article

Seroprevalence of Anti-Sars-CoV-2 Antibodies in Patients with Inflammatory Bowel Disease

2023-01-16

Abstract excerpt

<title>Abstract</title> <p>Patients with inflammatory bowel disease (IBD) treated with biologic and/or immunosuppressant drugs are at increased risk for opportunistic infections. Seroprevalence studies can confirm the diagnosis of SARS-CoV-2 infections as well as the associated risk factors. This is a descriptive study which primary endpoints were to highlight the prevalence of SARS-CoV-2 antibodies in a cohort o...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5eec9755-0986-50d7-8cba-4666fa03927b
DOI
10.21203/rs.3.rs-2331169/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Seroprevalence of Anti-Sars-CoV-2 Antibodies in Patients with Inflammatory Bowel DiseaseDOI 10.21203/rs.3.rs-2331169/v1
Serological response to COVID-19 vaccination in IBD patients receiving biologicsSemantic proximity
COVID-19 and Inflammatory Bowel Diseases: risk assessment, shared molecular pathways and therapeutic challengesSemantic proximity
Patients with Inflammatory Bowel Disease on anti-Tumor Necrosis Factor Therapy Might be Predisposed to SARS-CoV-2 Variants Infection Even after Receiving a Third mRNA Vaccine DoseSemantic proximity
Antibody Responses to SARS-CoV-2 after Infection or Vaccination in Children and Young Adults with Inflammatory Bowel DiseaseSemantic proximity
COVID-19 Vaccine-Induced Antibody Responses are Impaired in IBD Patients Treated with Infliximab or Tofacitinib, but not Thiopurines, Ustekinumab or VedolizumabSemantic proximity
COVID-19 Vaccine Hesitancy Among Patients with Inflammatory Bowel Disease on Biologic Therapies; A cross-sectional studySemantic proximity
Reduced SARS-CoV-2 infection levels and pathotype specific altered antiviral transcriptional response in IBD intestinal organoidsSemantic proximity
Detection of Fecal SARS-CoV-2 RNA in a Prospective Cohort of Children with Multisystem Inflammatory Syndrome (MIS-C)Semantic proximity
Adverse Events Following SARS-CoV-2 mRNA Vaccination Among Patients with Inflammatory Bowel DiseaseSemantic proximity
The Incidence of Immune Mediated Inflammatory Diseases Following COVID-19: a Matched Cohort Study in UK Primary CareSemantic proximity
Attitudes towards Vaccinations in a National Italian Cohort of Patients with Inflammatory Bowel DiseaseSemantic proximity
Accelerated waning of immunity to SARS-CoV-2 mRNA vaccines in patients with immune mediated inflammatory diseasesSemantic proximity
Select a neighboring publication to make it the new centre.